{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:01:39Z","timestamp":1790740899909,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["HXQMX0152"],"award-info":[{"award-number":["HXQMX0152"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["2021HXFH001"],"award-info":[{"award-number":["2021HXFH001"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303669"],"award-info":[{"award-number":["82303669"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["2021CDZG-23"],"award-info":[{"award-number":["2021CDZG-23"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["ZYJC21046"],"award-info":[{"award-number":["ZYJC21046"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012551","name":"Sichuan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2026NSFSC1896"],"award-info":[{"award-number":["2026NSFSC1896"]}],"id":[{"id":"10.13039\/100012551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020207","name":"Sichuan Province Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020207","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tranon.2026.102959","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:47:27Z","timestamp":1785232047000},"page":"102959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oprozomib inhibits proliferation and promotes apoptosis in gallbladder carcinoma cells through MAPK signaling pathway"],"prefix":"10.1016","volume":"72","author":[{"given":"Fei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Wen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2026.102959_bib0001","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl 1","key":"10.1016\/j.tranon.2026.102959_bib0002","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hep.31325","article-title":"Surgical treatments of hepatobiliary cancers","volume":"73","author":"Gunasekaran","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.tranon.2026.102959_bib0003","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.suc.2018.12.008","article-title":"Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies","volume":"99","author":"Hickman","year":"2019","journal-title":"Surg. Clin. North Am."},{"issue":"3","key":"10.1016\/j.tranon.2026.102959_bib0004","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","article-title":"Carcinoma of the gallbladder","volume":"4","author":"Misra","year":"2003","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102959_bib0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.suronc.2018.05.007","article-title":"A predictive model for survival of gallbladder adenocarcinoma","volume":"27","author":"Yifan","year":"2018","journal-title":"Surg. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102959_bib0006","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12885-018-5211-y","article-title":"Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin","volume":"19","author":"You","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2026.102959_bib0007","article-title":"Gemcitabine-based chemotherapy for advanced biliary tract carcinomas","volume":"4","author":"Abdel-Rahman","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.tranon.2026.102959_bib0008","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejso.2018.08.020","article-title":"The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - a systematic review","volume":"45","author":"Hakeem","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.tranon.2026.102959_bib0009","first-page":"99","article-title":"Gallbladder cancer: epidemiology and outcome","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.tranon.2026.102959_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1042\/bse0410187","article-title":"The ubiquitin-proteasome system and cancer","volume":"41","author":"Devoy","year":"2005","journal-title":"Essays Biochem."},{"key":"10.1016\/j.tranon.2026.102959_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2019.100663","article-title":"Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance","volume":"48","author":"Narayanan","year":"2020","journal-title":"Drug Resist. Updat."},{"issue":"7","key":"10.1016\/j.tranon.2026.102959_bib0012","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2016.206","article-title":"Proteasome inhibitors in cancer therapy","volume":"14","author":"Manasanch","year":"2017","journal-title":"Nature Rev. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.102959_bib0013","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-pharmtox-010919-023603","article-title":"Proteasome inhibitor drugs","volume":"60","author":"Fricker","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tranon.2026.102959_bib0014","article-title":"Bortezomib for the treatment of multiple myeloma","volume":"4","author":"Scott","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.tranon.2026.102959_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(15)00464-7","article-title":"Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study","volume":"17","author":"Dimopoulos","year":"2016","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102959_bib0016","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1411321","article-title":"Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma","volume":"372","author":"Stewart","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.tranon.2026.102959_bib0017","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S1470-2045(20)30452-6","volume":"21","author":"Kumar","year":"2020","journal-title":"Lancet Oncol."},{"issue":"23","key":"10.1016\/j.tranon.2026.102959_bib0018","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1182\/blood-2010-04-276626","article-title":"A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma","volume":"116","author":"Chauhan","year":"2010","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.tranon.2026.102959_bib0019","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1158\/1078-0432.CCR-12-1213","article-title":"Carfilzomib and ONX 0912 inhibit cell survival and tumor growth of head and neck cancer and their activities are enhanced by suppression of Mcl-1 or autophagy","volume":"18","author":"Zang","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"15","key":"10.1016\/j.tranon.2026.102959_bib0020","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/WNR.0000000000001320","article-title":"Overexpression of immunoproteasome low-molecular-mass polypeptide 7 and inhibiting role of next-generation proteasome inhibitor ONX 0912 on cell growth in glioma","volume":"30","author":"Min","year":"2019","journal-title":"Neuroreport"},{"key":"10.1016\/j.tranon.2026.102959_bib0021","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbrc.2021.02.037","article-title":"ONX0912, a selective oral proteasome inhibitor, triggering mitochondrial apoptosis and mitophagy in liver cancer","volume":"547","author":"Wu","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.tranon.2026.102959_bib0022","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/abbs\/gmz093","article-title":"An oral second-generation proteasome inhibitor oprozomib significantly inhibits lung cancer in a p53 independent manner in vitro","volume":"51","author":"Zhu","year":"2019","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"10","key":"10.1016\/j.tranon.2026.102959_bib0023","doi-asserted-by":"crossref","first-page":"350","DOI":"10.21037\/atm-22-1203","article-title":"Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1","volume":"11","author":"Yang","year":"2023","journal-title":"Ann. Transl. Med."},{"issue":"12","key":"10.1016\/j.tranon.2026.102959_bib0024","first-page":"1689","article-title":"Micro-RNA 21Targets dual specific phosphatase 8 to promote collagen synthesis in high glucose-treated primary cardiac fibroblasts","volume":"30","author":"Liu","year":"2014","journal-title":"Can. J. Cardiol."},{"issue":"6","key":"10.1016\/j.tranon.2026.102959_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27646","article-title":"Mechanism of Bazi Bushen capsule in delaying the senescence of mesenchymal stem cells based on network pharmacology and experimental validation","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.tranon.2026.102959_bib0026","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/nprot.2006.235","article-title":"Detection of apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling and acridine orange in Drosophila embryos and adult male gonads","volume":"1","author":"Arama","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tranon.2026.102959_bib0027","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.toxicon.2020.07.007","article-title":"Trim CM: kinome scale profiling of venom effects on cancer cells reveals potential new venom activities","volume":"185","author":"McCullough","year":"2020","journal-title":"Toxicon"},{"issue":"20","key":"10.1016\/j.tranon.2026.102959_bib0028","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1182\/blood-2009-09-243402","article-title":"Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia","volume":"115","author":"Roccaro","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.tranon.2026.102959_bib0029","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2174\/1574892816666210224155403","article-title":"STAT3 inhibitor napabucasin inhibits tumor growth and cooperates with proteasome inhibition in human ovarian cancer cells","volume":"16","author":"Liu","year":"2021","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.tranon.2026.102959_bib0030","article-title":"Suppression of proteasome induces apoptosis in APL cells and increases chemo-sensitivity to arsenic trioxide: proposing a perception in APL treatment","volume":"26","author":"Zamani-Moghaddam","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"issue":"12","key":"10.1016\/j.tranon.2026.102959_bib0031","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/sj.cdd.4401130","article-title":"Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe","volume":"9","author":"Castedo","year":"2002","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.tranon.2026.102959_bib0032","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4161\/cc.3.6.906","article-title":"Regulation of Cdc25C activity during the meiotic G2\/M transition","volume":"3","author":"Perdiguero","year":"2004","journal-title":"Cell Cycle"},{"issue":"8","key":"10.1016\/j.tranon.2026.102959_bib0033","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/cancers11081178","article-title":"p21 in cancer research","volume":"11","author":"Shamloo","year":"2019","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.tranon.2026.102959_bib0034","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1534-5807(04)00131-5","article-title":"Skp2-mediated degradation of p27 regulates progression into mitosis","volume":"6","author":"Nakayama","year":"2004","journal-title":"Dev. Cell"},{"issue":"16","key":"10.1016\/j.tranon.2026.102959_bib0035","first-page":"3153","article-title":"Two new competing pathways establish the threshold for cyclin-B-Cdk1 activation at the meiotic G2\/M transition","volume":"129","author":"Hiraoka","year":"2016","journal-title":"J. Cell. Sci."},{"issue":"6","key":"10.1016\/j.tranon.2026.102959_bib0036","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.tjog.2016.09.003","article-title":"Carfilzomib induces G2\/M cell cycle arrest in human endometrial cancer cells via upregulation of p21(Waf1\/Cip1) and p27(Kip1)","volume":"55","author":"Zhou","year":"2016","journal-title":"Taiwan J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102959_bib0037","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.onc.1201543","article-title":"Ducommun B: p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells","volume":"16","author":"Cayrol","year":"1998","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.tranon.2026.102959_bib0038","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cellsig.2010.01.013","article-title":"Examination of the expanding pathways for the regulation of p21 expression and activity","volume":"22","author":"Jung","year":"2010","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.tranon.2026.102959_bib0039","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1021\/jf4037722","article-title":"Induction of p21(Waf1\/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer","volume":"62","author":"Yu","year":"2014","journal-title":"J. Agric. Food Chem."},{"issue":"15","key":"10.1016\/j.tranon.2026.102959_bib0040","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.bmcl.2014.05.083","article-title":"Xylarianaphthol-1, a novel dinaphthofuran derivative, activates p21 promoter in a p53-independent manner","volume":"24","author":"Kotoku","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.tranon.2026.102959_bib0041","doi-asserted-by":"crossref","first-page":"603","DOI":"10.18632\/aging.100934","article-title":"Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies","volume":"8","author":"Pistritto","year":"2016","journal-title":"Aging"},{"issue":"3","key":"10.1016\/j.tranon.2026.102959_bib0042","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1081-1206(10)63176-6","article-title":"Apoptosis","volume":"78","author":"Fleisher","year":"1997","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"6","key":"10.1016\/j.tranon.2026.102959_bib0043","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.21873\/anticanres.15072","article-title":"Ubiquitin-proteasome system is a promising target for killing cisplatin-resistant bladder cancer cells","volume":"41","author":"Okubo","year":"2021","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.tranon.2026.102959_bib0044","first-page":"697","article-title":"Carfilzomib activates ER stress and JNK\/p38 MAPK signaling to promote apoptosis in hepatocellular carcinoma cells","volume":"56","author":"Deng","year":"2024","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.tranon.2026.102959_bib0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-cellbio-100913-013226","article-title":"Regulated cell death: signaling and mechanisms","volume":"30","author":"Ashkenazi","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.tranon.2026.102959_bib0046","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.biochem.73.011303.073706","article-title":"Cytochrome C-mediated apoptosis","volume":"73","author":"Jiang","year":"2004","journal-title":"Annu. Rev. Biochem."},{"issue":"7","key":"10.1016\/j.tranon.2026.102959_bib0047","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrm2434","article-title":"Cytochrome c: functions beyond respiration","volume":"9","author":"Ow","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5303","key":"10.1016\/j.tranon.2026.102959_bib0048","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.275.5303.1129","article-title":"Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked","volume":"275","author":"Yang","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.tranon.2026.102959_bib0049","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","article-title":"Compromised MAPK signaling in human diseases: an update","volume":"89","author":"Kim","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tranon.2026.102959_bib0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bcp.2016.12.008","article-title":"Romidepsin induces G2\/M phase arrest via Erk\/cdc25C\/cdc2\/cyclinB pathway and apoptosis induction through JNK\/c-Jun\/caspase3 pathway in hepatocellular carcinoma cells","volume":"127","author":"Sun","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102959_bib0051","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2478\/acph-2021-0012","article-title":"Norcantharidin induces G2\/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells","volume":"71","author":"Huang","year":"2021","journal-title":"Acta Pharm."},{"issue":"11","key":"10.1016\/j.tranon.2026.102959_bib0052","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10495-017-1422-y","article-title":"Piperlongumine induces G2\/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway","volume":"22","author":"Thongsom","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.tranon.2026.102959_bib0053","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bcp.2019.07.008","article-title":"Ginsenoside Rg5 induces G2\/M phase arrest, apoptosis and autophagy via regulating ROS-mediated MAPK pathways against human gastric cancer","volume":"168","author":"Liu","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102959_bib0054","first-page":"647","article-title":"Oridonin induces G2\/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells","volume":"24","author":"Wang","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tranon.2026.102959_bib0055","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6571674","article-title":"Cucurbitacin D induces G2\/M phase arrest and apoptosis via the ROS\/p38 pathway in Capan-1 pancreatic cancer cell line","volume":"2020","author":"Kim","year":"2020","journal-title":"Evid. Based Complement Alternat. Med."},{"issue":"5","key":"10.1016\/j.tranon.2026.102959_bib0056","first-page":"2347","article-title":"Next-generation proteasome inhibitor oprozomib enhances sensitivity to doxorubicin in triple-negative breast cancer cells","volume":"11","author":"Shi","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:40:28Z","timestamp":1790739628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326002950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":56,"alternative-id":["S1936523326002950"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102959","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oprozomib inhibits proliferation and promotes apoptosis in gallbladder carcinoma cells through MAPK signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102959"}}